Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics
  • the committee is based on a system of peer review
  • the committee is independent

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.

New proposals IRC

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’
  • the Gavi's strategic goals

It also ensures that each new application for support complies with the eligibility criteria, established according to the Gavi guidelines for new proposals of support.


Round opening
(on the portal)

Deadline for submission

IRC meeting
(indicative dates)

~2mths prior

20 January 2022

14–25 March 2022

~2mths prior

25 April 2022

20 June–1 July 2022

~2mths prior

18 July 2022

20–30 September 2022

~2mths prior

13 September 2022

7-18 November 2022

    IRC Membership

    Members of the Independent Review Committee consist of specialists from a broad range of expertise.

    IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

    Range of expertise

    The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

    • Routine immunisation programmes, especially at country level
    • Management of campaigns
    • Delivery of health services including child and adolescent health
    • Health systems strengthening and management
    • Epidemiology and disease control
    • Cold chain and logistics
    • Financial and budget analysis
    • Gender and equity

    The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

    Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

    List of IRC pool members



    Areas of expertise

    1 Borja Cuervo Alonso Access to primary healthcare services in low resource settings; HSS; disaster risk reduction; emergency relief; support to refugees and IDPs
    2 Beatriz Ayala-Öström HSS, supply chain management and resilience, system investments for vaccine preventable pandemics, project management, implementation and evaluations
    3 Saidou Pathé Barry HSS, national health strategies, policy dialogue in the health sector, M&E, primary health care
    4 Sabine Beckmann Public health, community-based primary health care, routine and mass vaccination campaigns and supply chain management, M&E, technical assistance
    5 Blaise Bikandou HSS, policy development, vaccine preventable diseases, epidemiology, health programme management and administration
    6 Francois Boilloit Disease control, health system development and reform, health financing, development assistance for health
    7 Brent Burkholder Epidemiology, vaccine programmes and disease control, outbreak investigations
    8 Diego Buriot Public health interventions, communicable diseases, fragile and crisis settings
    9 Lisa Cairns Immunisation policy, epidemiology, M&R control, national immunisation programme reviews
    10 Aleksandra Caric Immunisation, vaccine safety and regulation, programme management and administration
    11 Valerie Chambard iSC Expert in vaccine management, EVM assessment and cold chain inventory and gap analysis
    12 Dah Cheikh Organization and management of vaccination programmes, HSS, vaccine campaigns, trainings
    13 Sadia Chowdhury Reproductive Health, HSS, child health services, programme delivery, M&E of health programmes
    14 John Crump Infectious diseases, epidemiology, outbreak responses, typhoid
    15 Henrique D’Alva Cold chain, EPI logistics
    16 Teklay Desta Managing immunization program, Vaccine Preventable Disease surveillance and outbreak investigation, New vaccine introduction and data management
    17 Ousmane Dia HSS, project/program management, capacity building, supply chain management of health commodities, vaccine and cold chain management
    18 Modibo Dicko Supply chain management, introducing innovative technologies, management systems and practices in health supply systems
    19 Mohamed Dramé HSS, health policy dialogue, process & impact evaluation, health financing, human resource for health, community health, immunization systems
    20 Rene Dubbeldam National health policies, essential medicines strategies, child health programmes, community health, epidemiology
    21 Linda O'Neal Eckert Infectious diseases, vaccine preventable disease policy and program development, epidemiology
    22 Tene-Alima Essoh Vaccine clinical development and advocacy for market access,HSS, new vaccine introduction, strategies addressing vaccine hesitancies and pharmacovigilance.   
    23 Peter Fonkwo Health programme design and management, routine &mass campaigns vaccination, HSS, EPI M&E
    24 Kate Gallagher Infectious disease epidemiology and vaccine delivery
    25 Djordie Gikic HSS, proposal development, immunisation systems evaluation, service delivery, health policies
    26 Melita Gordon Gastroenterology, disease surveillance, typhoid, vaccine trials
    27 John Grundy Health policy, campaign delivery, HSS, programme evaluation
    28 Bradley Hersh Health policy, immunisation, outbreaks, campaigns, measles control
    29 Natasha Howard Health policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background
    30 Hector Izurieta Immunisation campaign management, public health, measles control, epidemiology, policy making
    31 Barbara Johnson Public health laboratory assessments, diagnostic laboratory training, development differential diagnostic testing algorithms, improving diagnostic assays
    32 Jean Rostand Kamga Financial & budget analysis, management and governance, audits, financial investigations
    33 Toagoe Karzon Project funding, financial reporting and budget control, conducting audits
    34 Tcha Landry Kaucley Cold Chain, vaccine logistics, EPI monitoring & evaluation, public health management
    35 Wassim Khrouf Financial & budget analysis, audits, project assessment
    36 Joses Kirigia HSS efficiency and productivity analysis; costing and economic evaluation of public health programmes;  analysis of economic burden of disease
    37 Per Kronslev Pharmaceutical supply chains serving public health
    38 Stefano Lazzari Outbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management
    39 Dafrossa Lyimo Immunisation campaign management, public health, health systems management, health policies, disease control
    40 Tippi Mak Vaccinology and scientific reviews for immunisation policy, safety and regulation. Late-phase vaccine development, epidemiologic research and primary care
    41 Osman Mansoor Immunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics
    42 Viviana Mangiaterra Child health, epidemiology, HSS, immunisation programmes
    43 Florian Marks Public health, vaccinology and policy making, outbreak responses, campaign evaluations
    44 Anne McArthur-Lloyd NVS introduction; immunization system strengthening and assessment; training and community engagement
    45 Scott McKeown Epidemiology, information systems, health service delivery, immunization incl. campaigns, cold chain maintenance
    46 Mark Miller Epidemiology, vaccine research, public health, outbreak investigations, disease control
    47 Kondwani Msampha   Financial & budget analysis, HSS, global health and integrated service delivery
    48 Vittal Mogasale Health and vaccine Economics, communicable diseases control, epidemiology, surveillance, advocacy and policy
    49 Sandra Mounier-Jack Immunisation programmes, health systems strengthening, HPV vaccine, measles elimination, health policy and health financing
    50 Pierre Corneille Namahoro Cold-chain logistics, health and pharmaceutical  supply chain, HSS, project design and management, M&E and financial management
    51 Alex Nartey Health financing, public financial management, project management, funds and grants management
    52 Benjamin Nkowane Vaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health
    53 Mathieu Noirhomme Public health, HSS, health policy dialogue, health financing, design thinking & service design, universal health coverage
    54 Cornelius Oepen HSS, urban health, health security, mass vaccination/campaigns, evaluation of research programmes
    55 Jean Marc Olive Immunisation programmes, emergency strategies & disaster relief, measles elimination
    56 Bolanle Oyeledun Health systems strengthening, MNCH, immunisation, adolescent reproductive health & HPV, programme assessments and evaluations
    57 Femi Oyewole Role of laboratories in disease control at various levels of health care delivery. Designing, implementing and evaluating activities in the area of vaccine-preventable diseases
    58 Michael Park Programme management and evaluation, primary care, health systems and public health
    59 Elisabeth Paul Health systems and policies, health financing, universal health coverage, performance-based financing, aid effectiveness
    60 Obed Philip Procurement and supply chain management and governance, vaccines management and system design, public health logistics management
    61 Giorgi Pkhakadze Public health, HSS, project/program design, planning, M&E, control of communicable and non-communicable diseases, change management
    62 Bastiaan Remmelzwaal  Cold chain and vaccine management, EVM assessments, Facility and Equipment Maintenance and Inventories and pharmaceutical supply chain management
    63 Chandrakant Ruparelia HSS, disease outbreak response, innovations to improve access to healthcare, and integration of health services, implementation of national guidelines, quality improvement
    64 Helen Saxenian Health financing, public financial management, costing, economic evaluation, public-private engagement in immunization, fiscal policies for health
    65 Jim Setzer Health information systems, HSS, disease surveillance, programme and policy planning, M&E, strategic planning
    66 Craig Shapiro Management of immunisation programmes, policy development, public health, cold chain evaluation, HSS activities
    67 Simon (Sam) Sternin Global health generalist, HSS, disaster management, coverage and equity, CSOs
    68 Gavin Surgey Health economics and financing; HSS; health technology assessment
    69 Ousmane Amadou Sy Financial and grant management; technical assistance; public health policy; program design/planning and implementation; health and community systems strengthening
    70 Patricia Taylor Routine immunization, new vaccine introduction, MNBCH, community and urban health, health information systems, capacity development
    71 Joanne Thomson Public health, gender equality, disability and social inclusion, development of humanitarian good practice standards, programme design and evaluation
    72 Abdelmajid Tibouti Financial & budget analysis, health economics, health financing strategies, monitoring and evaluation
    73 Oyewale T. Tomori  Laboratory systems and support for infectious disease prevention, diagnosis and control
    74 Vivien Tsu Epidemiology, new public health interventions, women's reproductive health, HPV, JE
    75 Beena Varghese Evaluation of health interventions including cost and cost-effectiveness analysis; design of research methods for health systems analyses; and health financing
    76 Margaret Watkins Immunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations
    77 Karen Wilkins Immunisation campaign management, proposals development, monitoring and evaluation, DQ assessments
    78 Charles Shey Wiysonge Vaccinology, HSS, vaccine hesitancy, epidemiology, systematic reviews, programme management
    79 Aregai Woldegebriel Epidemiology, SIA, MNCH, outbreaks, monitoring and evaluation


    Consolidated IRC reports

    November 27, 2019

    IRC reports

    Last updated: 23 Nov 2021

    Subscribe to our newsletter